Choosing a tumor‐specific target gene, exclusively expressed in cancerous cells and vital for their survival, can mitigate off‐tumor activity risks specifically arising from the knockout of the target.[22] SOX2 is a critical transcription factor for embryogenesis and stem cell pluripotency. The gene discussed is SOX2; the disease is neoplasm.